Study of Arimoclomol in Inclusion Body Myositis (IBM)
Condition: Inclusion Body MyositisInterventions: Drug: Arimoclomol; Other: PlaceboSponsors: University of Kansas Medical Center; FDA Office of Orphan Products DevelopmentNot yet recruiting - verified April 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials